Annual Cash & Cash Equivalents
$12.65 M
-$34.35 M-73.09%
December 31, 2022
Summary
- As of February 9, 2025, NMTR annual cash & cash equivalents is $12.65 million, with the most recent change of -$34.35 million (-73.09%) on December 31, 2022.
- During the last 3 years, NMTR annual cash & cash equivalents has risen by +$8.05 million (+175.34%).
Performance
NMTR Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$6.94 M
-$5.71 M-45.13%
March 31, 2023
Summary
- As of February 9, 2025, NMTR quarterly cash and cash equivalents is $6.94 million, with the most recent change of -$5.71 million (-45.13%) on March 31, 2023.
- Over the past year, NMTR quarterly cash and cash equivalents has dropped by -$30.30 million (-81.37%).
Performance
NMTR Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
NMTR Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -73.1% | -81.4% |
| 3 y3 years | +175.3% | +160.1% |
| 5 y5 years | +3456.3% | -46.5% |
NMTR Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -73.1% | at low | -85.2% | at low |
| 5 y | 5-year | -73.1% | -63.7% | -89.2% | -61.6% |
| alltime | all time | -73.1% | -100.0% | -89.2% | -99.4% |
9 Meters Biopharma Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $6.94 M(-45.1%) |
| Dec 2022 | $12.65 M(-73.1%) | $12.65 M(-20.3%) |
| Sep 2022 | - | $15.86 M(-46.2%) |
| Jun 2022 | - | $29.46 M(-20.9%) |
| Mar 2022 | - | $37.24 M(-20.8%) |
| Dec 2021 | $46.99 M(+24.2%) | $46.99 M(-12.3%) |
| Sep 2021 | - | $53.61 M(-16.3%) |
| Jun 2021 | - | $64.02 M(+66.3%) |
| Mar 2021 | - | $38.50 M(+1.7%) |
| Dec 2020 | $37.85 M(+724.1%) | $37.85 M(+204.4%) |
| Sep 2020 | - | $12.44 M(-7.7%) |
| Jun 2020 | - | $13.47 M(+405.1%) |
| Mar 2020 | - | $2.67 M(-41.9%) |
| Dec 2019 | $4.59 M(-19.8%) | $4.59 M(-48.2%) |
| Sep 2019 | - | $8.86 M(-33.5%) |
| Jun 2019 | - | $13.34 M(+16.0%) |
| Mar 2019 | - | $11.49 M(+100.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $5.73 M(+1511.1%) | $5.73 M(-29.4%) |
| Sep 2018 | - | $8.11 M(-23.9%) |
| Jun 2018 | - | $10.66 M(-17.8%) |
| Mar 2018 | - | $12.98 M(+3549.2%) |
| Dec 2017 | $355.60 K(-75.5%) | $355.60 K(+104.4%) |
| Sep 2017 | - | $174.00 K(+346.2%) |
| Jun 2017 | - | $39.00 K(-74.0%) |
| Mar 2017 | - | $150.00 K(-89.7%) |
| Dec 2016 | $1.45 M(+1121.0%) | $1.45 M(-51.1%) |
| Sep 2016 | - | $2.97 M(+1853.9%) |
| Jun 2016 | - | $152.00 K(+261.9%) |
| Mar 2016 | - | $42.00 K(-64.7%) |
| Dec 2015 | $119.00 K(+22.7%) | $119.00 K(+120.4%) |
| Sep 2015 | - | $54.00 K(-49.1%) |
| Jun 2015 | - | $106.00 K(+9.3%) |
| Dec 2014 | $97.00 K(+9600.0%) | $97.00 K |
| Dec 2013 | $1000.00 | - |
FAQ
- What is 9 Meters Biopharma annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for 9 Meters Biopharma?
- What is 9 Meters Biopharma annual cash & cash equivalents year-on-year change?
- What is 9 Meters Biopharma quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for 9 Meters Biopharma?
- What is 9 Meters Biopharma quarterly cash and cash equivalents year-on-year change?
What is 9 Meters Biopharma annual cash & cash equivalents?
The current annual cash & cash equivalents of NMTR is $12.65 M
What is the all time high annual cash & cash equivalents for 9 Meters Biopharma?
9 Meters Biopharma all-time high annual cash & cash equivalents is $46.99 M
What is 9 Meters Biopharma annual cash & cash equivalents year-on-year change?
Over the past year, NMTR annual cash & cash equivalents has changed by -$34.35 M (-73.09%)
What is 9 Meters Biopharma quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of NMTR is $6.94 M
What is the all time high quarterly cash and cash equivalents for 9 Meters Biopharma?
9 Meters Biopharma all-time high quarterly cash and cash equivalents is $64.02 M
What is 9 Meters Biopharma quarterly cash and cash equivalents year-on-year change?
Over the past year, NMTR quarterly cash and cash equivalents has changed by -$30.30 M (-81.37%)